BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 18649354)

  • 1. Absence of Ras mutations in rat DMBA-induced mammary tumors.
    Samuelson E; Nilsson J; Walentinsson A; Szpirer C; Behboudi A
    Mol Carcinog; 2009 Feb; 48(2):150-5. PubMed ID: 18649354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of p53 and Ha-ras gene mutations in chemically induced rat mammary carcinomas.
    Kito K; Kihana T; Sugita A; Murao S; Akehi S; Sato M; Tachibana M; Kimura S; Ueda N
    Mol Carcinog; 1996 Oct; 17(2):78-83. PubMed ID: 8890956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allelic imbalance in mammary carcinomas induced by either 7,12-dimethylbenz[a]anthracene or ionizing radiation in rats carrying genes conferring differential susceptibilities to mammary carcinogenesis.
    Haag JD; Hsu LC; Newton MA; Gould MN
    Mol Carcinog; 1996 Nov; 17(3):134-43. PubMed ID: 8944073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of H-ras oncogenes in preneoplastic mouse mammary tissues.
    Kumar R; Medina D; Sukumar S
    Oncogene; 1990 Aug; 5(8):1271-7. PubMed ID: 2118247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of p53 and ras gene mutations in DMBA-induced rat leukemias.
    Wei S; Kito K; Miyoshi A; Matsumoto S; Kauzi A; Aramoto T; Abe Y; Ueda N
    J Exp Clin Cancer Res; 2002 Sep; 21(3):389-96. PubMed ID: 12385583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased susceptibility to NMU-induced mammary carcinogenesis in transgenic rats carrying multiple copies of a rat ras gene driven by the rat Harvey ras promoter.
    Thompson TA; Haag JD; Lindstrom MJ; Griep AE; Lohse JK; Gould MN
    Oncogene; 2002 Apr; 21(18):2797-804. PubMed ID: 11973638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An expression study of hormone receptors in spontaneously developed, carcinogen-induced and hormone-induced mammary tumors in female Noble rats.
    Cheung SY; Yuen MT; Choi HL; Cheng HK; Huang Y; Chen S; Chan FL
    Int J Oncol; 2003 Jun; 22(6):1383-95. PubMed ID: 12739009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Both (+/-)syn- and (+/-)anti-7,12-dimethylbenz[a]anthracene-3,4-diol-1,2-epoxides initiate tumors in mouse skin that possess -CAA- to -CTA- mutations at Codon 61 of c-H-ras.
    Tang MS; Vulimiri SV; Viaje A; Chen JX; Bilolikar DS; Morris RJ; Harvey RG; Slaga TJ; DiGiovanni J
    Cancer Res; 2000 Oct; 60(20):5688-95. PubMed ID: 11059761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. c-H-ras-1 expression in 7,12-dimethyl benzanthracene-induced Balb/c mouse mammary hyperplasias and their tumors.
    Cardiff RD; Gumerlock PH; Soong MM; Dandekar S; Barry PA; Young LJ; Meyers FJ
    Oncogene; 1988 Aug; 3(2):205-13. PubMed ID: 2842717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High susceptibility of transgenic rats carrying the human c-Ha-ras proto-oncogene to chemically-induced mammary carcinogenesis.
    Tsuda H; Asamoto M; Ochiya T; Toriyama-Baba H; Naito A; Ota T; Sekiya T; Terada M
    Mutat Res; 2001 Jun; 477(1-2):173-82. PubMed ID: 11376698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purple grape juice inhibits 7,12-dimethylbenz[a]anthracene (DMBA)-induced rat mammary tumorigenesis and in vivo DMBA-DNA adduct formation.
    Jung KJ; Wallig MA; Singletary KW
    Cancer Lett; 2006 Feb; 233(2):279-88. PubMed ID: 15878797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequent mutations of the Trp53, Hras1 and beta-catenin (Catnb) genes in 1,3-butadiene-induced mammary adenocarcinomas in B6C3F1 mice.
    Zhuang SM; Wiseman RW; Söderkvist P
    Oncogene; 2002 Aug; 21(36):5643-8. PubMed ID: 12165863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absence of p53 mutations in methylnitrosourea-induced mammary tumors in rats.
    Ogawa K; Tokusashi Y; Fukuda I
    Cancer Detect Prev; 1996; 20(3):214-7. PubMed ID: 8769715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gpx2 is an overexpressed gene in rat breast cancers induced by three different chemical carcinogens.
    Naiki-Ito A; Asamoto M; Hokaiwado N; Takahashi S; Yamashita H; Tsuda H; Ogawa K; Shirai T
    Cancer Res; 2007 Dec; 67(23):11353-8. PubMed ID: 18056462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flow cytometric analysis of DMBA-induced early in vivo ras expression.
    Gyöngyi Z; Grama L; Nádasi E; Sándor J; Németh A; Varga C; Kiss I; Ember I
    In Vivo; 2002; 16(5):323-6. PubMed ID: 12494871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations in H-ras1 promoter conformation during N-nitroso-N-methylurea-induced mammary carcinogenesis and pregnancy.
    Jin Z; Houle B; Mikheev AM; Cha RS; Zarbl H
    Cancer Res; 1996 Nov; 56(21):4927-35. PubMed ID: 8895746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of ras oncogenes in the initiation of carcinogen-induced tumors.
    Barbacid M
    Princess Takamatsu Symp; 1986; 17():43-53. PubMed ID: 3332020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estradiol and progesterone can prevent rat mammary cancer when administered concomitantly with carcinogen but do not modify surviving tumor histology, estrogen receptor alpha status or Ha-ras mutation frequency.
    Swanson SM; Christov K
    Anticancer Res; 2003; 23(4):3207-13. PubMed ID: 12931682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonrandom abnormalities involving chromosome 1 and Harvey-ras-1 alleles in rat mammary tumor progression.
    Aldaz CM; Chen A; Gollahon LS; Russo J; Zappler K
    Cancer Res; 1992 Sep; 52(17):4791-8. PubMed ID: 1511443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequent codon 12 Ki-ras mutations in mouse skin tumors initiated by N-methyl-N'-nitro-N-nitrosoguanidine and promoted by mezerein.
    Rehman I; Lowry DT; Adams C; Abdel-Fattah R; Holly A; Yuspa SH; Hennings H
    Mol Carcinog; 2000 Apr; 27(4):298-307. PubMed ID: 10747294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.